glp-1 cardiovascular outcome trials Summary of with SGLT-2 inhibitors and The Multidisciplinary Approach to GLP-1

Sage ( Salvia officinalis L.): A botanical marvel with versatile pharmacological properties and sustainable applications in functional foods

9,10 This could be attributed to natriuresis and the improved function of the vascular endothelium facilitated by the release of nitric oxide

Han Z, Kokkonen GC, Roth GS

The search strategy incorporated terms related to GLP-1 receptor agonists (e.g., GLP-1, Semaglutide, Liraglutide, Exenatide) in combination with alcohol use concepts (e.g., alcohol, alcohol use disorder, binge drinking, ethanol)

The drugs skyrocketed in mainstream popularity after the Food and Drug Administration began approving GLP-1 medications for weight loss over the last five years, in addition to their pre-existing approvals to treat diabetes

The first cohort (study group) contained patients with a diagnosis of MASLD/MASH who received any GLP-1 agonist after the first instance of diagnosis (i.e., MASLD/MASH)